< Getting ready to rumble | Main | The sociological importance of hoops >
January 13, 2006
The bidding over Guidant heats up
In response to Johnson & Johnson's increased bet earlier this week for heart-device maker Guidant, Boston Scientific has matched J&J's bet and upped the ante.
Gee, wasn't it just a few weeks ago that J&J was getting assistance from the Lord of Regulation in driving the price of Guidant down?
Boston Scientific's sweetened bid is valued at $25.55 billion and gives Guidant's board board until Friday afternoon to fish or cut bait on the offer. Boston Scientific's new offer is valued at $73 per Guidant share (up from its earlier $72 per share offer) and deletes most of the conditions in prior bid that made J&J's competing offer (valued at $67.92 per Guidant share) look to be more likely to close and, thus, a better risk for Guidant. What a far cry from the $56 per share price of Guidant's shares just two months ago when J&J was threatening to walk the deal.
Update: Guidant Corp.'s board accepted the Johnson & Johnson offer late Friday and rejected the larger but potentially more time-consuming competing Boston Scientific offer. The agreement is valued at $24.2 billion, consisting of $40.52 in cash and .493 shares of J&J stock for each Guidant share and is scheduled to close as early as Jan. 31. Boston Scientific -- which, unlike J&J, would have still had to obtain government regulatory approval of its bid -- had hoped to close its proposed deal by March 31.
Posted by Tom at January 13, 2006 05:30 AM
Trackback Pings
TrackBack URL for this entry:
http://mtcgi.kir.com/mt-trackbk.cgi/2784
Comments
Post a comment
Thanks for signing in, . Now you can comment. (sign out)
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)